Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

QIAGEN NV buy Barclays PLC

Start price
€40.47
02.10.25 / 50%
Target price
€45.15
02.10.26
Performance (%)
-
Price
-
-
Summary
This prediction has just been started. It does not have a price yet.. This prediction currently runs until 02.10.26. The prediction end date can be changed by Barclays_PLC at any time.
Performance without dividends (%)
Name 1w
QIAGEN NV -
iShares Core DAX® -0.693%
iShares Nasdaq 100 -1.173%
iShares Nikkei 225® -1.388%
iShares S&P 500 -1.411%

Comments by Barclays_PLC for this prediction

In the thread QIAGEN NV diskutieren
Prediction Buy
Perf. (%) -
Target price 45.151
Change
Ends at 02.10.26

QIAGEN (NYSE:QGEN) was given a new $53.00 price target on by analysts at Barclays PLC. They now have an "overweight" rating on the stock.
Ratings data for QGEN provided by MarketBeat

Stopped prediction by Barclays_PLC for QIAGEN NV

buy
QIAGEN NV

Start price
Target price
Perf. (%)
€40.47
24.06.25
€47.45
24.06.26
-
29.01.24